Unforeseen Cancer Development After Morcellation

Financial compensation may be available to females who have been diagnosed with uterine leiomyosarcoma following a laparoscopic hysterectomy or uterine fibroid removal surgery.  To qualify, the female must have undergone a surgery in which the procedure included the use of a morcellator, a power device used to cut the uterine tissue before it is suctioned out with minimal incisions. The leading pharmaceutical company, Johnson & Johnson, is now recalling thousands of morcellators nationwide.

This issue was presented when a woman developed uterine leiomyosarcoma after having a laparoscopic hysterectomy. She was not examined or diagnosed with any cancers before the procedure was performed.  During the shredding of the uterus, fibroids and cells containing malignant cancers spread to other areas of her body, resulting in an advanced stage of cancer. Doctors have never been called performed examinations in search of cancers prior to a hysterectomy, so this was not a routine gone badly.  It was the poor manufacturing of the medical device in which the problem was discovered. J&J are currently facing hundreds of cases nationwide against women affected by their product.

FDA Investigation for Morcellator

After investigations by the FDA and a recall by J&J, these women are still left with one scary beast to defeat: cancer.  The negligent acts of a pharmaceutical manufacturer will be tamed, however, justice must be served for the innocent women affected by the morcellators.

Morcellator Cancer Lawsuit

If you or a loved one has developed uterine leiomyosarcoma or the spread of any cancer following a invasive, laparoscopy hysterectomy, an attorney from The Willis Law Firm is willing to review your potential claim. An action against the manufactures could result in compensation for your pain and suffering.  Call today for your FREE consultation and legal advice.  Our experts are waiting to talk with you.  Call The Willis Law Firm at 1-800-883-9858.